top of page

Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. („INBS“ or the „Company“) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that President and CEO, Harry Simeonidis, and CFO, Spiro Sakiris, are scheduled to present at the LD Micro Invitational XIV Investor Conference to be held on April 8-9, 2024 in New York City. Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

Aktuelle Beiträge

Alle ansehen

Comments


bottom of page